https://www.indianpharmapost.com/usfda-inspection-at-indoco-remediess-solid-oral-formulation-facility-at-goa-136382023-01-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-launches-akynzeo-iv-in-india-136392023-01-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/marksans-pharma-announces-uk-mhra-approval-for-fluoxetine-20mg5ml-oral-solution-136402023-01-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/syngene-q3fy23-revenue-reaches-rs-803-cr-pat-reaches-rs-110-cr-136412023-01-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/gland-pharmas-q3-fy23-revenue-stood-at-rs-938-cr-with-gross-margin-of-54-136422023-01-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/supriya-lifescience-appoints-krishna-raghunathan-as-cfo-136432023-01-24T00:00:00+05:30always0.9